Gender and brain disease
Posted: Mon Oct 24, 2005 2:07 am
She said that most of the drugs available today had been tested on men, which may mean they are not necessarily the best design for women.
It makes you want to look closer at the 30% average relapse reduction on the CRAB drugs. Who was leaning to the higher side in those trials.
Does anyone have that type of info.